|
5-30-12
|
Somatic Mosaic Activating Mutations in PIK3CA Cause CLOVES Syndrome |
|
5-24-12
|
Phenotypic progression of skeletal anomalies in CLOVES syndrome |
|
1-2011
|
WT1-Related Wilms Tumor (WT) Syndromes | The Children's Hospital of Philadelphia |
|
8-2011
|
What is a gene mutation and how do mutations occur? |
|
3-2011
|
Sirolimus for the treatment of complicated vascular anomalies in children |
|
3-2011
|
Here is a link to the video of our conference in Boston on 3-19-2011. This video wraps up Dr. Alomari's discussion and shows Dr. Warman's discussion about the proposed research |
|
2-2011
|
Complex spinal and paraspinalfast flow lesions - in Cloves Syndrome |
|
11-2010
|
Webcast from Brussels (International Soceity for the Study of Vascular Anomalies) about CLOVES |
|
11-2010
|
Perinatal clinical and imaging features of CLOVES syndrome |
|
4-2010
|
Extracranial arteriovenous malformations: natural progression and recurrence after treatment |
|
2010
|
CLOVES and phlebectasia - increased risk of pulmonary embolism |
|
2010
|
An early description of CLOVES |
|
12-2009
|
CLOVES Syndrome 12-12-2009 described by Dr Alomari |
|
10-2009
|
Clinical Trial Assessing Efficacy and Safety of the mTOR Inhibitor Sirolimus in the Treatment of Complicated Vascular Anomalies - Completion date 2013 |
|
4-2009
|
Pharmacological treatment of a diffuse arteriovenous malformation of the upper extremity in a child |
|
10-2008
|
CLOVE(S) syndrome-expanding the acronym |
|
10-2008
|
CLOVES Syndrome - CNS Malformations and Seizures |
|
6-2008
|
Percutaneous sclerotherapy of lymphatic malformations with doxycycline. |
|
2008
|
CLOVES Syndrome - Clinical Dysmorphology -18 Cases |
|
4-2007
|
The spectrum of vascular anomalies in patients with PTEN mutations: implications for diagnosis and management. |
|
2007
|
CLOVE Syndrome seen in 7 patients (7-2007) |
|
2007
|
Cutaneous Manifestations of CLOVES Syndrome |
